IP Library Granted Patent US 11,767,523
Granted Patent B2
US 11,767,523 · App. 16/332,674 · Granted Sep 26, 2023

Acrylamide copolymerization for sequestration and production of single-stranded nucleic acid

Inventors: Elisha Krieg (Dresden, DE); William M. Shih (Cambridge, MA)
Assignee: Dana-Farber Cancer Institute, Inc.
C12N15/1006C08F220/56C12N15/1017C12Q1/6806C08J2333/26C12N2310/00C12N2330/30C12Q2523/305C12Q2523/32C12Q2525/204
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,767,523
App. No.
16/332,674
Granted
Sep 26, 2023
Kind
B2
Abstract

Provided herein, in some embodiments, are methods, compositions and kits for large-scale production of long single-stranded DNA in solution.

Claims (25)

1. A method of producing single-stranded deoxyribonucleic acid (ssDNA), comprising:

(a) combining in solution acrylamide-labeled double-stranded deoxyribonucleic acid (dsDNA) and acrylamide (AA) monomers to form copolymer-linked dsDNA in solution;

(b) dehybridizing the copolymer-linked dsDNA in solution to produce free ssDNA and DNA-containing copolymer; and

(c) separating the free ssDNA from the solution of (b).

2. The method of claim 1 , wherein separating the free ssDNA from the solution of (b) comprises adding methanol to the solution of (b) to selectively precipitate the DNA-containing copolymer.

3. The method of claim 1 , wherein the length of the dsDNA is 100-10,000 nucleotide base pairs.

4. The method of claim 1 , wherein the concentration of acrylamide monomers in the solution is 10-100 mg/ml.

5. The method of claim 1 , wherein the concentration of acrylamide-labeled dsDNA in the solution is 0.01-10 mg/ml.

6. The method of claim 1 , wherein the solution comprises ammonium persulfate (APS) and tetramethylethylenediamine (TEMED).

7. The method of claim 6 , wherein the solution comprises ammonium persulfate at a concentration of 0.01 wt %-0.05 wt % and/or wherein solution comprises TEMED at a concentration of 0.01 wt %-0.05 wt %.

8. The method of claim 1 , wherein the solution further comprises acrylate (A).

9. The method of claim 8 , wherein the ratio of AA:A is 50:1 to 200:1.

10. The method of claim 8 , wherein the copolymer-linked dsDNA comprises a linear copolymer.

11. The method of claim 1 , wherein the solution comprises ammonium persulfate at a concentration of 0.0005 wt %-0.002 wt % and/or tetramethylethylenediamine (TMED) at a concentration of 0.0005 wt %-0.002 wt %.

12. The method of claim 1 , wherein the solution further comprises a crosslinking agent.

13. The method of claim 12 , wherein the crosslinking agent comprises bisacrylamide (BAA), piperazine diacrylamide, N,N′-Hexamethylenebis(methacrylamide), N,N′-ethylenebis(acrylamide), or combinations thereof.

14. The method of claim 13 , wherein the BAA is N,N-methylenebisacrylamide.

15. The method of claim 13 , wherein the ratio of AA:BAA in the solution is 9:1 to 1:1.

16. The method of claim 12 , wherein the copolymer-linked dsDNA comprises a crosslinked copolymer.

17. The method of claim 1 , wherein the copolymer-linked dsDNA comprises at least 80% of the acrylamide-labeled dsDNA from the solution.

18. The method of claim 1 , further comprising incubating the solution of (a) for 1-3 hours.

19. The method of claim 1 , wherein the dehybridizing of (b) comprises combining the copolymer-linked dsDNA with an aqueous buffer comprising (i) sodium hydroxide and ethylenediaminetetraacetic acid (EDTA); (ii) formamide and EDTA; or (iii) Tris-EDTA.

20. The method of claim 16 , wherein the crosslinked copolymer has a molecular weight of at least 1000 kDa.

21. The method of claim 16 , wherein the separating comprises passing the solution of (b) over a microfiltration membrane to remove the crosslinked DNA-containing copolymer.

22. The method of claim 16 , wherein the separating comprises subjecting the solution of (b) to centrifugation to remove the crosslinked DNA-containing copolymer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2019
From: KRIEG, ELISHA; SHIH, WILLIAM M.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 049917/0352 →
CONFIRMATORY LICENSE Recorded May 13, 2019
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 049161/0457 →
Continuity (2)
Provisional Application 62393600 · Sep 12, 2016
Related Publication 20200190505A1 · Jun 18, 2020